Helicobacter pylori eradication therapy modulates acidity and interleukin-1beta mRNA levels in un-operated stomach and in remnant stomach after gastrectomy in gastric cancer patients

Operated Stomach ◽

Gastric Cancer Patients ◽

Helicobacter pylori eradication therapy modulates acidity and interleukin-1β mRNA levels in un-operated stomach and in remnant stomach after gastrectomy in gastric cancer patients

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2006.00057.x ◽

2007 ◽

Vol 24 ◽

pp. 278-284 ◽

Cited By ~ 4

Author(s):

S. KATO ◽

N. MATSUKURA ◽

N. MATSUDA ◽

K. TSUKADA ◽

Z. NAITO ◽

...

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Cancer Patients ◽

Eradication Therapy ◽

Remnant Stomach ◽

Mrna Levels ◽

Operated Stomach ◽

Gastric Cancer Patients ◽

Preoperative Versus Postoperative Helicobacter pylori Eradication Therapy in Gastric Cancer Patients: A Randomized Trial

The American Journal of Gastroenterology ◽

10.1111/j.1572-0241.2007.01482.x ◽

2008 ◽

Vol 103 (1) ◽

pp. 48-54 ◽

Cited By ~ 6

Author(s):

Chan Gyoo Kim ◽

Ho June Song ◽

Myeong-Cherl Kook ◽

Eun Kyung Hong ◽

Sohee Park ◽

...

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Randomized Trial ◽

Cancer Patients ◽

Eradication Therapy ◽

Gastric Cancer Patients ◽

Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study

Case Medical Research ◽

10.31525/ct1-nct03978481 ◽

2019 ◽

Author(s):

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Retrospective Study ◽

Survival Rate ◽

Cancer Patients ◽

Subtotal Gastrectomy ◽

Gastric Cancer Patients

Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model

Digestive Diseases and Sciences ◽

10.1007/s10620-019-05910-1 ◽

2019 ◽

Vol 65 (6) ◽

pp. 1679-1688 ◽

Cited By ~ 4

Author(s):

Yan Han ◽

Tianlian Yan ◽

Han Ma ◽

Xin Yao ◽

Chao Lu ◽

...

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Cost Effectiveness ◽

Markov Model ◽

Eradication Therapy ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Su1363 HELICOBACTER PYLORI ERADICATION THERAPY EFFECTIVELY IMPROVES GASTRIC CANCER DEVELOPMENT IN AN EAST ASIAN POPULATION: META-ANALYSIS

Gastroenterology ◽

10.1016/s0016-5085(20)32117-x ◽

2020 ◽

Vol 158 (6) ◽

pp. S-566

Author(s):

Mitsushige Suglmoto ◽

Masaki Murata ◽

Takao Itoi ◽

Takashi Kawai ◽

Yoshio Yamaoka

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Meta Analysis ◽

East Asian ◽

Eradication Therapy ◽

Asian Population ◽

East Asian Population ◽

Cancer Development ◽

Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer

Patient Preference and Adherence ◽

10.2147/ppa.s286860 ◽

2021 ◽

Vol Volume 15 ◽

pp. 77-85

Author(s):

Hanrui Zheng ◽

Qian Xie ◽

Mei Zhan ◽

Chaohui Jin ◽

Qiu Li

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Cost Effectiveness ◽

Eradication Therapy ◽

Cost Effectiveness Analysis ◽

First Degree Relatives ◽

Effectiveness Analysis ◽

Su1982 – Mucosa-Associated Microbiota in the Upper Gut in Patients with Early Gastric Cancer After Successful Helicobacter Pylori Eradication Therapy

Gastroenterology ◽

10.1016/s0016-5085(19)38616-0 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-681

Author(s):

Takahiro Nakano ◽

Tomohisa Takagi ◽

Osamu Dohi ◽

Yuka Azuma ◽

Tsugitaka Ishida ◽

...

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Early Gastric Cancer ◽

Eradication Therapy ◽

Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study

Gastric Cancer ◽

10.1007/s10120-014-0404-9 ◽

2014 ◽

Vol 18 (3) ◽

pp. 612-617 ◽

Cited By ~ 10

Author(s):

Kazuhide Higuchi ◽

Toshihisa Takeuchi ◽

Noriya Uedo ◽

Yoji Takeuchi ◽

Yuji Naito ◽

...

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Early Gastric Cancer ◽

Standard Treatment ◽

Eradication Therapy ◽

Efficacy And Safety ◽

Prospective Multicenter Study ◽

Randomized Controlled ◽

Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases

Journal of Gastroenterology ◽

10.1007/s00535-006-1924-9 ◽

2007 ◽

Vol 42 (S17) ◽

pp. 21-27 ◽

Cited By ~ 85

Author(s):

Susumu Take ◽

Motowo Mizuno ◽

Kuniharu Ishiki ◽

Yasuhiro Nagahara ◽

Tomowo Yoshida ◽

...

Keyword(s):

Gastric Cancer ◽

Helicobacter Pylori ◽

Risk Factor ◽

Peptic Ulcer ◽

Eradication Therapy ◽

Mucosal Atrophy ◽

Gastric Mucosal Atrophy ◽

Helicobacter Pylori Eradication Therapy ◽

Development Of Gastric Cancer

Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review

Journal of Gastroenterology ◽

10.1007/s00535-009-0036-8 ◽

2009 ◽

Vol 44 (5) ◽

pp. 365-371 ◽

Cited By ~ 51

Author(s):

Masanori Ito ◽

Shunsuke Takata ◽

Masana Tatsugami ◽

Yoshihiro Wada ◽

Shinobu Imagawa ◽

...

Keyword(s):

Gastric Cancer ◽

Systematic Review ◽

Helicobacter Pylori ◽

Eradication Therapy ◽

Clinical Prevention ◽